Stewart W Strong Haemonetics Corp (HAE) insider trading activity

Stewart W Strong is President, Global Hospital of HAEMONETICS CORP. Currently has a direct ownership of 18,196 shares of HAE, which is worth approximately $1.56 Million. The most recent transaction as insider was on Jul 26, 2024, when has been sold 4,312 shares (Common Stock) at a price of $91.15 per share, resulting in proceeds of $393,038. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 18.2K

0% 3M change

13.01% 12M change

Total Value Held $1.56 Million

Stewart W Strong Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 26 2024	SELL Open market or private sale	$393,038 $91.15 p/Share	4,312 Reduced 19.16%	18,196 Common Stock
Jul 25 2024	SELL Payment of exercise price or tax liability	$253,442 $90.58 p/Share	2,798 Reduced 11.06%	22,508 Common Stock
Jul 24 2024	BUY Grant, award, or other acquisition	-	7,110 Added 21.93%	25,306 Common Stock
May 29 2024	SELL Open market or private sale	$775,253 $87.53 p/Share	8,857 Reduced 32.74%	18,196 Common Stock
May 28 2024	SELL Payment of exercise price or tax liability	$421,116 $95.73 p/Share	4,399 Reduced 13.99%	27,053 Common Stock
May 28 2024	BUY Grant, award, or other acquisition	-	13,256 Added 29.65%	31,452 Common Stock
May 20 2024	SELL Open market or private sale	$65,245 $95.11 p/Share	686 Reduced 3.63%	18,196 Common Stock
May 20 2024	SELL Payment of exercise price or tax liability	$147,849 $95.08 p/Share	1,555 Reduced 7.61%	18,882 Common Stock
May 20 2024	BUY Exercise of conversion of derivative security	$126,773 $56.57 p/Share	2,241 Added 9.88%	20,437 Common Stock
May 17 2024	SELL Payment of exercise price or tax liability	$27,187 $95.73 p/Share	284 Reduced 1.82%	15,324 Common Stock
May 17 2024	BUY Grant, award, or other acquisition	-	2,872 Added 13.63%	18,196 Common Stock
May 16 2024	SELL Payment of exercise price or tax liability	$184,161 $95.47 p/Share	1,929 Reduced 10.56%	16,341 Common Stock
May 16 2024	SELL Open market or private sale	$70,397 $96.04 p/Share	733 Reduced 4.49%	15,608 Common Stock
May 16 2024	BUY Exercise of conversion of derivative security	$138,816 $57.6 p/Share	2,410 Added 11.8%	18,018 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$23,254 $96.49 p/Share	241 Reduced 1.5%	15,860 Common Stock
Oct 20 2023	SELL Payment of exercise price or tax liability	$10,686 $89.05 p/Share	120 Reduced 0.74%	16,101 Common Stock
Sep 12 2023	SELL Open market or private sale	$20,668 $90.65 p/Share	228 Reduced 1.39%	16,221 Common Stock
Jun 07 2023	SELL Open market or private sale	$223,445 $88.04 p/Share	2,538 Reduced 13.37%	16,449 Common Stock
Jun 07 2023	SELL Payment of exercise price or tax liability	$444,664 $88.0 p/Share	5,053 Reduced 21.02%	18,987 Common Stock
Jun 07 2023	BUY Exercise of conversion of derivative security	$393,452 $57.08 p/Share	6,893 Added 22.28%	24,040 Common Stock
May 18 2023	SELL Payment of exercise price or tax liability	$90,590 $83.34 p/Share	1,087 Reduced 5.96%	17,147 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$22,302 $89.21 p/Share	250 Reduced 1.35%	18,234 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	-	2,803 Added 13.17%	18,484 Common Stock
Oct 24 2022	SELL Open market or private sale	$6,029 $80.39 p/Share	75 Reduced 0.48%	15,681 Common Stock
May 19 2022	SELL Open market or private sale	$64,064 $59.1 p/Share	1,084 Reduced 6.44%	15,756 Common Stock

SWS

Stewart W Strong

President, Global Hospital

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HAE shares.

Notify only if

Value

Insider Trading

Get notified when an Haemonetics Corp insider buys or sells HAE shares.

Notify only if

Operation

Value

Type

News

Receive news related to HAEMONETICS CORP

Track Activities on HAE

Account